In the course of investigating the autophagy mechanism in glioma cells, Western blot analysis unveiled a pivotal finding: sh-DNM1L treatment led to a significant down-regulation of ATG5 and LC3-II protein expression in glioma cells, concurrently accompanied by a pronounced increase in p62 protein levels. The gene discussed is DNM1L; the disease is central nervous system cancer.